Status:
ACTIVE_NOT_RECRUITING
Microneedling Versus Carboxytherapy in Stria Distensae Rubra
Lead Sponsor:
Alexandria University
Conditions:
Striae Distensae
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate and compare the efficacy and safety of microneedling and carboxytherapy either with or without platelet-rich plasma in the treatment of striae distensae rubra.
Eligibility Criteria
Inclusion
- Female patients.
- Age ranging from 18-45 years old.
- Fitzpatrick skin type III-IV.
- Striae distensae rubra on the abdomen (bilateral and more or less symmetrical).
Exclusion
- Patients taking immunosuppressants or having any disease affecting wound healing including diabetes.
- Patients receiving systemic glucocorticoids for chronic health conditions.
- Patients with chronic dermatologic diseases such as psoriasis and vitiligo.
- Pregnant and lactating females.
- Patients with a tendency for keloid formation.
- Patients with endocrine disturbance.
- Patients with autoimmune diseases, systemic diseases such as severe anemia, respiratory, cardiac, renal or liver disorder.
- Patients with bleeding and coagulation disorders.
- Patients who received any form of treatment for their SD in the past 6 months.
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07001644
Start Date
October 1 2022
End Date
December 1 2025
Last Update
June 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria Faculty of Medicine
Alexandria, Egypt